#USA #New York #Nabla #AI Assistant #Brian Manning

Nabla Appoints Brian Manning as New CEO

Nabla, a leader in clinical AI solutions, has recently appointed Brian Manning as its new Chief Executive Officer, signifying a new chapter in the company's growth trajectory in healthcare technology. This strategic decision comes as Nabla aims to leverage AI capabilities for enhancing clinical efficacy and streamlining healthcare operations.

With over 20 years of rich experience in scaling technology companies, Manning is poised to steer Nabla towards further growth. His track record includes significant roles, notably as President and Chief Revenue Officer at Bamboo Health, where he played an instrumental role in scaling the company to annual recurring revenues over $140 million. During his tenure, he developed a formidable go-to-market organization, underscoring his ability to foster high-performing teams and drive enterprise growth.

Nabla's Aspirational Mission

Manning's arrival at Nabla aligns perfectly with the company's objective to enhance clinical workflows through innovative AI solutions. As he steps into his role, he expressed enthusiasm about the unique blend of Nabla's mission and its commitment to delivering high-value solutions for healthcare organizations. He recognizes that healthcare institutions increasingly seek partners that can provide immediate value while preparing them for the future of AI.

"What attracted me to Nabla is the combination of its outstanding team, crucial mission, product excellence, and customer obsession," Manning remarked. This marks a commitment to not only uphold the current standards but also to push the envelope in clinical AI designed for modern healthcare.

Future Growth Strategy

Nabla currently supports over 190 healthcare organizations and 100,000 clinicians, facilitating approximately 40 million patient encounters annually. Its robust integration with major Electronic Health Records (EHR) like Epic and Oracle Cerner exemplifies its capability to create a seamless interface within existing infrastructures. New partnerships with industry leaders like NextGen Healthcare and athenahealth further enhance its national reach.

The leadership team, which includes co-founders Alex LeBrun and Delphine Groll, emphasizes a continuous commitment to innovation and customer-centric solutions. LeBrun remains actively involved in the company's long-term AI strategies as the Executive Chairman and Chief AI Officer.

The vision moving forward includes advancing Nabla's Contextual Clinical Intelligence, which integrates AI into clinical workflows. Manning's leadership is expected to accelerate this vision by fostering a culture of innovation that can navigate the complexities of modern healthcare.

Conclusion

As Nabla embarks on this new journey under Manning’s leadership, the potential for transforming healthcare delivery through AI is immense. The combination of cutting-edge technology and industry expertise underscores Nabla’s commitment to being at the forefront of clinical AI. This strategic appointment marks a significant step towards solidifying Nabla’s position as the optimal clinical AI partner for healthcare organizations globally. With a focus on enhancing efficiency and patient experience, the company is set to pioneer advancements that will shape the future landscape of healthcare technology.